#JPM24: Paul Hudson is ‘open-minded’ to M&A as he plots Sanofi’s transformation

SAN FRANCISCO — Sanofi CEO Paul Hudson reiterated his ambitions for the “new” Sanofi, including business development plans ahead of what some experts predict will be a busy year for M&A in the biopharma sector.

Hudson said Tuesday during an investor presentation at the JP Morgan Healthcare Conference that he’s…
Click here to view original post